Development of new generation rinderpest vaccines
- PMID: 14677680
Development of new generation rinderpest vaccines
Abstract
Veterinary science has benefited much from the advances in biotechnology during the past 20 years. New and improved diagnostic techniques for infectious diseases have been developed and new and highly effective vaccines to prevent such diseases have been introduced and more have been, or are about to be, field-tested. The latest development in negative strand virology, reverse genetics, the ability to rescue live virus from a DNA copy of the RNA genome, is being used to address questions concerning virus pathogenicity at the molecular level and to produce "marker" vaccines, i.e. vaccines that allow serological identification of all vaccinated animals. Such a vaccine would greatly benefit the continuing campaign for the global eradication of rinderpest since it would then be possible, by serological means, to detect wild type virus circulating in local areas or regions where it is still necessary to vaccinate and where the vaccination levels are below those required to eliminate the virus. Here we describe different approaches we have taken to produce such a vaccine using reverse genetics to add a marker to the existing and widely used Plowright rinderpest vaccine.
Similar articles
-
Recombinant DNA technology for producing new rinderpest virus vaccines.Expert Rev Vaccines. 2005 Feb;4(1):113-20. doi: 10.1586/14760584.4.1.113. Expert Rev Vaccines. 2005. PMID: 15757478 Review.
-
Protective vaccination of ferrets against canine distemper with recombinant pox virus vaccines expressing the H or F genes of rinderpest virus.Am J Vet Res. 1997 Jun;58(6):590-3. Am J Vet Res. 1997. PMID: 9185963
-
A novel approach to generating morbillivirus vaccines: negatively marking the rinderpest vaccine.Vaccine. 2012 Mar 2;30(11):1927-35. doi: 10.1016/j.vaccine.2012.01.029. Epub 2012 Jan 20. Vaccine. 2012. PMID: 22265946
-
Development of a genetically marked recombinant rinderpest vaccine expressing green fluorescent protein.J Gen Virol. 2000 Mar;81(Pt 3):709-18. doi: 10.1099/0022-1317-81-3-709. J Gen Virol. 2000. PMID: 10675408
-
Vaccinia virus recombinant vaccines for rinderpest.Dev Biol Stand. 1995;84:201-8. Dev Biol Stand. 1995. PMID: 7796955 Review. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Miscellaneous